The FDA has approved a new 16 mg/4 mg buprenorphine-naloxone sublingual film to treat opioid dependence. Called Cassipa, it is made by Teva Pharmaceuticals USA Inc. In June, the FDA also approved the first generic versions of buprenorphine-naloxone sublingual film for opioid ...
Read MoreWomen are not getting the kind of opioid addiction treatment they should be getting. That’s not because women aren’t loved or appreciated. It’s ...
View MoreIn a strongly bipartisan 98-1 vote, the Senate has approved massive new legislation aimed at combating the opioid epidemic, and sent it on to the ...
View MoreDo you ever just take some of an opioid prescription, and then hang on to what’s left over in case you want it sometime in the future? This is not ...
View MoreA study from the UN's World Health Organization (WHO) has revealed that more than 3 million people died in 2016 as a result of the harmful use of ...
View MoreThe number of new heroin users across the nation in 2017 dropped to less than half those in 2016, says SAMHSA's 2017 National Survey on Drug Use and ...
View MoreAs part of National Recovery Month, NAADAC celebrates National Addiction Professionals Day every year in order to recognize the addiction ...
View MoreDrug traffickers, Ohio doctors’ offices, online fentanyl black markets, and illegal drugmakers in China, were the targets of a U.S. Department of ...
View MoreNovus writes inspirational stories of people in the news who have overcome addiction. This is not to imply that these people are connected to Novus ...
View MoreEvery September, the Substance Abuse and Mental Health Services Administration (SAMHSA) promotes National Recovery Month in order to increase ...
View More